The Canadian Stockbroker© | TCS newswire™ ; Private Client Good Morning Notes
Friday, October 21, 2005
Get A Good Morning Advantage With Blackmont "Private Client" services.
MARKET FLASH
8:43 AM - ATI Technologies Inc., (ATYT-NASD), SELL
Chartered Semi shows Xbox360 ramping up, confirms forecasts Bruce Krugel
Related Research
GOOD MORNING NOTES
8:31 AM - Your Good Morning Advantage
Transportation Securities
Pacific Gateway announcement to have positive implications for both CNR and CP Avi Dalfen
Related Research
Finning International, (FTT-TSX), BUY
Strike action to hit high-margin service revenues Avi Dalfen
Related Research
Zarlink Semiconductor Inc., (ZL-TSX), BUY
FQ2/06: profitability in sight, raising target to C$2.35 from C$2.20 Bruce Krugel
Related Research
Labopharm Inc., (DDS-TSX), BUY
3-year exclusivity? Biovail's Tramadol ER expected in FDA Orange Book today Carl Martel
Related Research
Cott Corporation, (COT-NYSE), HOLD
Cott in a rut; reducing target price to $17 David Hartley
Related Research
Rothmans Inc., (ROC-TSX), HOLD
Imperial Tobacco's shuttering of Cdn plants to arm company with more cash David Hartley
Related Research
Energy Post
Fundamentals unchanged Kurt Molnar
Related Research
Semafo Inc., (SMF-TSX), BUY
Q3 prod. results in line; bidding process for Managem block concludes next week Richard Gray
Related Research
Get A Good Morning Advantage With Blackmont "Private Client" services.
MARKET FLASH
8:43 AM - ATI Technologies Inc., (ATYT-NASD), SELL
Chartered Semi shows Xbox360 ramping up, confirms forecasts Bruce Krugel
Related Research
GOOD MORNING NOTES
8:31 AM - Your Good Morning Advantage
Transportation Securities
Pacific Gateway announcement to have positive implications for both CNR and CP Avi Dalfen
Related Research
Finning International, (FTT-TSX), BUY
Strike action to hit high-margin service revenues Avi Dalfen
Related Research
Zarlink Semiconductor Inc., (ZL-TSX), BUY
FQ2/06: profitability in sight, raising target to C$2.35 from C$2.20 Bruce Krugel
Related Research
Labopharm Inc., (DDS-TSX), BUY
3-year exclusivity? Biovail's Tramadol ER expected in FDA Orange Book today Carl Martel
Related Research
Cott Corporation, (COT-NYSE), HOLD
Cott in a rut; reducing target price to $17 David Hartley
Related Research
Rothmans Inc., (ROC-TSX), HOLD
Imperial Tobacco's shuttering of Cdn plants to arm company with more cash David Hartley
Related Research
Energy Post
Fundamentals unchanged Kurt Molnar
Related Research
Semafo Inc., (SMF-TSX), BUY
Q3 prod. results in line; bidding process for Managem block concludes next week Richard Gray
Related Research
0 Comments:
Post a Comment
<< Home